Energy metabolism dysregulation in schizophrenia with non-thyroidal illness syndrome: Roles of citric acid and Tyrosol-4-sulfate
Schizophrenia Research · 2026-09 · 295 · 179-186
DOI: 10.1016/j.schres.2026.06.007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Schizophrenia Research, 2026-09. Verfasst von Junhao Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Mental Health, Tianjin Anding Hospital, Mental Health Center of Tianjin Medical University, Tianjin, 300222, China; Brain Assessment & I…. Hauptthemen laut MEDLINE: Schizophrenia, Energy Metabolism, Citric Acid, Euthyroid Sick Syndromes. Die Arbeit nennt 51 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Tianjin Municipality.
Abstract (Originalsprache)
BACKGROUND: Non-Thyroidal Illness Syndrome (NTIS) is frequently observed in schizophrenia and is traditionally regarded as a peripheral endocrine disturbance. However, whether NTIS reflects a distinct metabolic phenotype linked to central energy dysregulation in schizophrenia remains unclear. We hypothesized that NTIS in schizophrenia reflects a distinct metabolic state characterized by disrupted energy metabolism, which may be linked to specific symptom dimensions. METHODS: A total of 185 patients with schizophrenia were enrolled and classified into NTIS and non-NTIS groups based on standard thyroid hormone criteria. Untargeted metabolomic profiling was performed using ultra-high-performance liquid chromatography high-resolution mass spectrometry. Differential metabolites were identified using Orthogonal-Partial-Least Squares-Discriminant-Analysis and Receiver Operating Characteristic curve analysis, followed by pathway enrichment analyses and regression analyses to examine associations with clinical symptoms. RESULTS: A total of 29 differential metabolites were screened (Variable Importance in Projection > 2, P - correction < 0.05), primarily related to amino acids and organic acids. Pathway enrichment analysis revealed significant perturbations in 10 metabolic pathways, with the TCA cycle (citrate cycle) (impact = 0.261, P < 0.0001). Two metabolites, Citric acid (AUC = 0.701, P < 0.05) and Tyrosol-4-sulfate (AUC = 0.703, P < 0.05) demonstrated good discriminative performance for NTIS status. These 2 metabolites were positively associated with the Visuospatial/Constructional dimension and negatively associated with positive symptoms in the NTIS group. CONCLUSIONS: Schizophrenia patients with NTIS display a distinct metabolic phenotype marked by TCA cycle dysregulation. Citric acid and tyrosol-4-sulfate may serve as metabolic indicators linking thyroid dysfunction to cognitive, psychotic symptoms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Mental Health, Tianjin Anding Hospital, Mental Health Center of Tianjin Medical University, Tianjin, 300222, China; Brain Assessment & Intervention Laboratory, Tianjin Anding Hospital, Mental Health Center…
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Tianjin Municipality
Zitieren
APA
Chen, J., Dong, Y., Li, Y., Liu, N., Wang, X., Han, Y., Li, Y., Guo, Y., Li, S., & Li, J. (2026). Energy metabolism dysregulation in schizophrenia with non-thyroidal illness syndrome: Roles of citric acid and Tyrosol-4-sulfate. Schizophrenia Research, 295, 179-186. https://doi.org/10.1016/j.schres.2026.06.007
Vancouver
Chen J, Dong Y, Li Y, Liu N, Wang X, Han Y, et al. Energy metabolism dysregulation in schizophrenia with non-thyroidal illness syndrome: Roles of citric acid and Tyrosol-4-sulfate. Schizophrenia Research. 2026;295:179-186. doi:10.1016/j.schres.2026.06.007
BibTeX
@article{Chen2026,
author = {Chen, Junhao and Dong, Yeqing and Li, Yanzhe and Liu, Nannan and Wang, Xinxu and Han, Yuxin and Li, Yue and Guo, Yueru and Li, Shen and Li, Jie},
title = {Energy metabolism dysregulation in schizophrenia with non-thyroidal illness syndrome: Roles of citric acid and Tyrosol-4-sulfate},
journal = {Schizophrenia Research},
year = {2026},
volume = {295},
pages = {179--186},
doi = {10.1016/j.schres.2026.06.007}
}
EUVIMED